MedPath

SHOEI UNIVERSAL CORPORATION PTE LTD

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

33

HSA:33

Drug Approvals

PENMIX DAPTOMYCIN POWDER FOR SOLUTION FOR INJECTION OR INFUSION 500MG/VIAL

Approval Date
Jun 27, 2023
HSA

DAC POWDER FOR INJECTION 200 mg/vial

Approval Date
Jan 10, 2004
HSA

DIOX POWDER FOR INJECTION 10 mg/vial

Approval Date
Jan 10, 2004
HSA

CEFTRIPHINE POWDER FOR INJECTION 1 g/vial

Approval Date
Jan 10, 2004
HSA

CEZOLIN INJECTION 1 gm/vial

Approval Date
Dec 5, 2003
HSA

LORACIN TABLET 10 mg

Approval Date
Nov 22, 2003
HSA

CLARI TABLET 500 mg

Approval Date
Jun 24, 2003
HSA

LAVOXEN TABLET 200 mg

Approval Date
May 22, 2003
HSA

RASPUTIN SOFT CAPSULE 0.25 mcg

Approval Date
Apr 25, 2003
HSA

RAMEZOL CAPSULE 20 mg

Approval Date
Jan 15, 2003
HSA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.